|
1
|
Chen M, Yang T, Meng X and Sun T:
Azithromycin attenuates cigarette smoke extract-induced oxidative
stress injury in human alveolar epithelial cells. Mol Med Rep.
11:3414–3422. 2015.
|
|
2
|
Lemjabbar-Alaoui H, Dasari V, Sidhu SS,
Mengistab A, Finkbeiner W, Gallup M and Basbaum C: Wnt and Hedgehog
are critical mediators of cigarette smoke-induced lung cancer. PLoS
One. 1:e932006.
|
|
3
|
Sasco AJ, Secretan MB and Straif K:
Tobacco smoking and cancer: A brief review of recent
epidemiological evidence. Lung Cancer. 45(Suppl 2): S3–S9.
2004.
|
|
4
|
Oh JJ, Razfar A, Delgado I, Reed RA,
Malkina A, Boctor B and Slamon DJ: 3p21.3 tumor suppressor gene
H37/Luca15/RBM5 inhibits growth of human lung cancer cells
through cell cycle arrest and apoptosis. Cancer Res. 66:3419–3427.
2006.
|
|
5
|
Mourtada-Maarabouni M, Sutherland LC,
Meredith JM and Williams GT: Simultaneous acceleration of the cell
cycle and suppression of apoptosis by splice variant delta-6 of the
candidate tumour suppressor LUCA-15/RBM5. Genes Cells. 8:109–119.
2003.
|
|
6
|
Zhao L, Li R, Shao C, Li P, Liu J and Wang
K: 3p21.3 tumor suppressor gene RBM5 inhibits growth of human
prostate cancer PC-3 cells through apoptosis. World J Surg Oncol.
10:2472012.
|
|
7
|
Welling DB, Lasak JM, Akhmametyeva E,
Ghaheri B and Chang LS: cDNA microarray analysis of vestibular
schwannomas. Otol Neurotol. 23:736–748. 2002.
|
|
8
|
Oh JJ, West AR, Fishbein MC and Slamon DJ:
A candidate tumor suppressor gene, H37, from the human lung
cancer tumor suppressor locus 3p21.3. Cancer Res. 62:3207–3213.
2002.
|
|
9
|
Rintala-Maki ND, Goard CA, Langdon CE,
Wall VE, Traulsen KE, Morin CD, Bonin M and Sutherland LC:
Expression of RBM5-related factors in primary breast tissue. J Cell
Biochem. 100:1440–1458. 2007.
|
|
10
|
Oh JJ, Grosshans DR, Wong SG and Slamon
DJ: Identification of differentially expressed genes associated
with HER-2/neu over-expression in human breast cancer cells.
Nucleic Acids Res. 27:4008–4017. 1999.
|
|
11
|
Wang W, Cassidy J, O'Brien V, Ryan KM and
Collie-Duguid E: Mechanistic and predictive profiling of
5-fluorouracil resistance in human cancer cells. Cancer Res.
64:8167–8176. 2004.
|
|
12
|
Sutherland LC, Wang K and Robinson AG:
RBM5 as a putative tumor suppressor gene for lung cancer. J Thorac
Oncol. 5:294–298. 2010.
|
|
13
|
Oh JJ, Taschereau EO, Koegel AK, Ginther
CL, Rotow JK, Isfahani KZ and Slamon DJ: RBM5/H37 tumor suppressor,
located at the lung cancer hot spot 3p21.3, alters expression of
genes involved in metastasis. Lung Cancer. 70:253–262. 2010.
|
|
14
|
Akhtar MJ, Ahamed M, Khan MA, Alrokayan
SA, Ahmad I and Kumar S: Cytotoxicity and apoptosis induction by
nanoscale talc particles from two different geographical regions in
human lung epithelial cells. Environ Toxicol. 29:394–406. 2014.
|
|
15
|
Niu Z, Jin W, Zhang L and Li X: Tumor
suppressor RBM5 directly interacts with the DExD/H-box protein
DHX15 and stimulates its helicase activity. FEBS Lett. 586:977–983.
2012.
|
|
16
|
Mourtada-Maarabouni M, Sutherland LC and
Williams GT: Candidate tumour suppressor LUCA-15 can regulate
multiple apoptotic pathways. Apoptosis. 7:421–432. 2002.
|
|
17
|
Mourtada-Maarabouni M, Keen J, Clark J,
Cooper CS and Williams GT: Candidate tumor suppressor
LUCA-15/RBM5/H37 modulates expression of apoptosis and cell cycle
genes. Exp Cell Res. 312:1745–1752. 2006.
|
|
18
|
Bechara EG, Sebestyén E, Bernardis I,
Eyras E and Valcárcel J: RBM5, 6, and 10 differentially regulate
NUMB alternative splicing to control cancer cell proliferation. Mol
Cell. 52:720–733. 2013.
|
|
19
|
Schamberger AC, Mise N, Jia J, Genoyer E,
Yildirim AÖ, Meiners S and Eickelberg O: Cigarette smoke-induced
disruption of bronchial epithelial tight junctions is prevented by
transforming growth factor-β. Am J Respir Cell Mol Biol.
50:1040–1052. 2014.
|
|
20
|
Du H, Sun J, Chen Z, Nie J, Tong J and Li
J: Cigarette smoke-induced failure of apoptosis resulting in
enhanced neoplastic transformation in human bronchial epithelial
cells. J Toxicol Environ Health A. 75:707–720. 2012.
|
|
21
|
Drabkin HA, West JD, Hotfilder M, Heng YM,
Erickson P, Calvo R, Dalmau J, Gemmill RM and Sablitzky F: DEF-3
(g16/NY-LU-12), an RNA binding protein from the 3p21.3 homozygous
deletion region in SCLC. Oncogene. 18:2589–2597. 1999.
|
|
22
|
Maarabouni MM and Williams GT: The
antiapoptotic RBM5/LUCA-15/H37 gene and its role in apoptosis and
human cancer: Research update. ScientificWorldJournal. 6:1705–1712.
2006.
|
|
23
|
Liang H, Zhang J, Shao C, Zhao L, Xu W,
Sutherland LC and Wang K: Differential expression of RBM5, EGFR and
KRAS mRNA and protein in non-small cell lung cancer tissues. J Exp
Clin Cancer Res. 31:362012.
|
|
24
|
Kobayashi T, Ishida J, Musashi M, Ota S,
Yoshida T, Shimizu Y, Chuma M, Kawakami H, Asaka M, Tanaka J, et
al: p53 transactivation is involved in the antiproliferative
activity of the putative tumor suppressor RBM5. Int J Cancer.
128:304–318. 2011.
|
|
25
|
Satyanarayana A and Kaldis P: Mammalian
cell-cycle regulation: Several Cdks, numerous cyclins and diverse
compensatory mechanisms. Oncogene. 28:2925–2939. 2009.
|
|
26
|
Hochegger H, Takeda S and Hunt T:
Cyclin-dependent kinases and cell-cycle transitions: Does one fit
all? Nat Rev Mol Cell Biol. 9:910–916. 2008.
|
|
27
|
Fung TK and Poon RY: A roller coaster ride
with the mitotic cyclins. Semin Cell Dev Biol. 16:335–342.
2005.
|
|
28
|
Hedberg Y, Ljungberg B, Roos G and
Landberg G: Retinoblastoma protein in human renal cell carcinoma in
relation to alterations in G1/S regulatory proteins. Int J Cancer.
109:189–193. 2004.
|
|
29
|
Vermeulen K, Van Bockstaele DR and
Berneman ZN: The cell cycle: A review of regulation, deregulation
and therapeutic targets in cancer. Cell Prolif. 36:131–149.
2003.
|
|
30
|
Lv XJ, Zhao LJ, Hao YQ, Su ZZ, Li JY, Du
YW and Zhang J: Schisandrin B inhibits the proliferation of human
lung adenocarcinoma A549 cells by inducing cycle arrest and
apoptosis. Int J Clin Exp Med. 8:6926–6936. 2015.
|
|
31
|
Fushimi K, Ray P, Kar A, Wang L,
Sutherland LC and Wu JY: Up-regulation of the proapoptotic caspase
2 splicing isoform by a candidate tumor suppressor, RBM5. Proc Natl
Acad Sci USA. 105:15708–15713. 2008.
|
|
32
|
Rintala-Maki ND and Sutherland LC:
LUCA-15/RBM5, a putative tumour suppressor, enhances multiple
receptor-initiated death signals. Apoptosis. 9:475–484. 2004.
|
|
33
|
Rintala-Maki ND, Abrasonis V, Burd M and
Sutherland LC: Genetic instability of RBM5/LUCA-15/H37 in MCF-7
breast carcinoma sublines may affect susceptibility to apoptosis.
Cell Biochem Funct. 22:307–313. 2004.
|
|
34
|
Sutherland LC, Lerman M, Williams GT and
Miller BA: LUCA-15 suppresses CD95-mediated apoptosis in Jurkat T
cells. Oncogene. 20:2713–2719. 2001.
|
|
35
|
Sleeman J and Steeg PS: Cancer metastasis
as a therapeutic target. Eur J Cancer. 46:1177–1180. 2010.
|
|
36
|
Verma S, Kesh K, Ganguly N, Jana S and
Swarnakar S: Matrix metalloproteinases and gastrointestinal
cancers: Impacts of dietary antioxidants. World J Biol Chem.
5:355–376. 2014.
|
|
37
|
Gencer S, Cebeci A and Irmak-Yazicioglu
MB: Matrix metalloproteinase gene expressions might be oxidative
stress targets in gastric cancer cell lines. Chin J Cancer Res.
25:322–333. 2013.
|
|
38
|
Ramakrishnan S, Subramanian IV, Yokoyama Y
and Geller M: Angiogenesis in normal and neoplastic ovaries.
Angiogenesis. 8:169–182. 2005.
|
|
39
|
Yamakuchi M, Lotterman CD, Bao C, Hruban
RH, Karim B, Mendell JT, Huso D and Lowenstein CJ: P53-induced
microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad
Sci USA. 107:6334–6339. 2010.
|
